A. Arnaiz-villena et al., Evolution of MHC-G in primates: a different kind of molecule for each group of species, J REPRO IMM, 43(2), 1999, pp. 111-125
When MHC-G molecules in primates (New World and Old World monkeys, Anthropo
ids and humans) were compared phylogenetically, very different evolutionary
patterns within each species were found; their molecules did not have a st
raight forward and linear development throughout the postulated evolutionar
y pathway of primates. The earlier New World monkeys (South America) had re
latively more alleles and the polymorphism was placed in the T-cell recepto
r (TcR), NK receptors and antigen binding sites; MHC-G probably works as a
classical class I presenting molecule in these monkeys. MHC-G intron 2 from
New World monkeys does not show the typical 23 bp deletion found in all ot
her more recent primate species. Thus, it is possible that MHC-G molecules
in New World monkeys belong to a different lineage than the MHC from higher
primates. Another early lineage, Eurasian Old World monkeys, shows stop co
dons at exon 3: MHC-G proteins lacking the alpha 2 domain may functionally
suffice or otherwise reading-through stop-codon translational mechanisms ma
y exist, as shown for other genes. Orangutans show lower (but significant)
polymorphism than New World monkeys at NK, TcR and antigen binding regions;
gorilla and chimpanzee show very low polymorphism. Humans only show three
different HLA-G proteins with changes not affecting NK, TcR or antigen bind
ing sites. It is observed that the more exposed the mother to allogeneic fe
tuses (polygamy), the less polymorphic HLA-G is observed within a given spe
cies. The data are concordant with the postulated immune inhibitory functio
n for MHC-G in Old World monkeys, anthropoids and humans both at placental
and inflammatory level. (C) 1999 Elsevier Science Ireland Ltd. All rights r
eserved.